About Contact Us Careers

Gastrointestinal Radiofrequency Ablation Systems Market Size and Forecast, by Type (Benchtop, Trolley); Application (Surgical Oncology, Pain Management, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology); and by End-user (Hospitals, Cancer Specialty Clinic) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4032
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT

Gastrointestinal Radiofrequency Ablation Systems Market Outlook:

Gastrointestinal Radiofrequency Ablation Systems Market size was over USD 4.54 billion in 2025 and is poised to exceed USD 9.01 billion by 2035, growing at over 7.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of gastrointestinal radiofrequency ablation systems is evaluated at USD 4.83 billion.

Gastrointestinal Radiofrequency Ablation Systems Market trends
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the growing incidence of cancer cases globally. RFA systems may become more popular as cancer rates rise since medical professionals are looking for less invasive ways to treat their patients. Globally over 6 million new instances of cancer will be reported among persons 80 years of age or older in 2050 which is more than 20% of all cancer cases.

In addition to these, factors that are believed to fuel the market growth of gastrointestinal radiofrequency ablation systems include the rise in technological advancements. For instance, RFA technology developments have resulted in the creation of more accurate and effective devices that can provide targeted energy to the damaged tissue with the least amount of harm to healthy tissue nearby. As a result, the method is now safer and more efficient, which may be causing RFA system demand to rise.

 

Key Gastrointestinal Radiofrequency Ablation Systems Market Insights Summary:

  • Regional Highlights:

    • North America is anticipated to capture a 35% share of the Gastrointestinal Radiofrequency Ablation Systems Market by 2035, stemming from the increasing incidence of stomach cancer.
    • Asia Pacific is projected to account for a 28% share by 2035, bolstered by the improving healthcare system.

  • Segment Insights:

    • The surgical oncology segment in the Gastrointestinal Radiofrequency Ablation Systems Market is projected to secure a 32% share by 2035, supported by the increasing prevalence of cancer.
    • The hospital segment is expected to command a 52% share by 2035, underpinned by hospitals’ capacity to provide the specialized tools and personnel required for gastrointestinal RFA procedures.

  • Key Growth Trends:

    • Growing Prevalence of Gastrointestinal Diseases
    • Increasing Health Spending

  • Major Challenges:

    • associated with Stomach Cancer
    • Devices for Gastrointestinal Radiofrequency Ablation Are Minimally Invasive

  • Key Players: ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc.

Global Gastrointestinal Radiofrequency Ablation Systems Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 4.54 billion
    • 2026 Market Size: USD 4.83 billion
    • Projected Market Size: USD 9.01 billion by 2035
    • Growth Forecasts: 7.1%

  • Key Regional Dynamics:

    • Largest Region: North America (35% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, Japan, Germany, United Kingdom
    • Emerging Countries: India, South Korea, Brazil, Singapore, United Arab Emirates

    • Last updated on : 21 November, 2025

Growth Drivers

  • Growing Prevalence of Gastrointestinal Diseases – On account of the increasing prevalence of gastrointestinal disorders such as Barrett's esophagus, gastroesophageal reflux disease (GERD), and colorectal cancer, the market is expected to expand more in the upcoming years. Further, RFA a less invasive and efficient therapeutic method is frequently useful in treating these types of disorders. According to a survey of over 70,000 people from 33 countries, it was discovered that more than 35% of adults have a functional gastrointestinal disease.
  • Increasing Health Spending – On account of the increase in health spending, hospitals, and healthcare providers may be able to invest in new medical technologies such as RFA systems, which as a result is estimated to drive market growth. According to the most recent data, in 2021, health spending in the US increased by over 2%.
  • Rising Geriatric Population – The elderly population is more prone to gastrointestinal conditions, and the rising number of elderly populations across the globe is estimated to drive market growth. According to the World Health Organization (WHO), the proportion of people over 60 years old in the world will nearly double from 12% to 22% by 2050.

Challenges

  • Challenges associated with Stomach Cancer The increasing concern amongst individuals for the difficult diagnosis of stomach cancer is one of the major factors predicted to slow down the market growth. For instance, RFA is frequently used to treat early-stage stomach cancer, which can be challenging to diagnose. As a result, the number of stomach cancer patients who qualify for RFA treatment may be reduced.
  • Devices for Gastrointestinal Radiofrequency Ablation Are Minimally Invasive
  • Exorbitant Treatment Costs

Gastrointestinal Radiofrequency Ablation Systems Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

7.1%

Base Year Market Size (2025)

USD 4.54 billion

Forecast Year Market Size (2035)

USD 9.01 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Gastrointestinal Radiofrequency Ablation Systems Market Segmentation:

Application (Surgical Oncology, Pain Management, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology, and Others)

The surgical oncology segment is estimated to gain the largest market share of 32% by the end of 2035. The growth of the segment can be attributed to the increasing prevalence of cancer across the globe. RFA is frequently utilized in surgical oncology as a complement to surgery, especially for the treatment of colon, liver, and pancreatic cancer. For instance, RFA can be used to either reduce the size of tumors before surgical resection or to remove any malignant tissue that may be left over after surgery. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years. By 2040, there will be over 16 million cancer-related deaths globally and more than 29 million new instances of cancer annually.

End-User (Hospitals, Cancer Specialty Clinic, and Others)

The hospital segment is expected to hold the largest share of 52% during the forecast period. Hospitals are well-equipped to supply the specific tools and skilled medical personnel that treatments involving the digestive system normally call for. Besides this, if there are any difficulties, patients receiving gastrointestinal RFA operations may need to spend the night in the hospital for observation and monitoring. As a result, it is projected that this would generate a lot of prospects for the segment's growth in the years to come.

Our in-depth analysis of the global market includes the following segments:

          By Type
  • Benchtop
  • Trolley

          By Application
  • Surgical Oncology
  • Pain Management
  • Cardiology & Cardiac Rhythm Management
  • Cosmetology
  • Gynecology
  • Others

          By End User
  • Hospitals
  • Cancer Specialty Clinic
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Gastrointestinal Radiofrequency Ablation Systems Market - Regional Analysis

North American Market Forecast

 North America industry is likely to dominate majority revenue share of 35% by 2035, attributed to increasing incidence of stomach cancer in the region.. The growth of the market can be attributed majorly to the increasing incidence of stomach cancer. There may be a growing demand for therapeutic options, such as RFA, as more cases of stomach cancer are discovered in the region. For instance, in some instances, gastrointestinal RFA may be a good alternative to surgery for the treatment of early-stage stomach cancer. Further, the presence of a strong healthcare network in the region, along with the growing usage of gastrointestinal radiofrequency ablation, is also anticipated to contribute to the market growth in the region.

APAC Market Statistics

The Asia Pacific gastrointestinal radiofrequency ablation systems market is estimated to be the second largest share of 28% by the end of 2035. The growth of the market can be attributed majorly to the improving healthcare system. Access to healthcare is one of the main advantages of improved healthcare systems for people in the region. This may lead to earlier diagnosis of gastrointestinal diseases, such as stomach cancer, and raise demand for RFA systems. In addition, funding for medical research and development may rise in the area as a result of improved healthcare systems. This may result in the development of fresh and ground-breaking medical innovations, such as improvements in gastrointestinal RFA. Further, the increasing prevalence of cancer in the region, along with the growing awareness about gastrointestinal radiofrequency ablation, are also anticipated to contribute to the market growth in the region.

Gastrointestinal Radiofrequency Ablation Systems Market value
Get Strategic Analysis by Region Now: Request Free Sample PDF

Gastrointestinal Radiofrequency Ablation Systems Market Players:

    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ATRICURE, INC.
    • Royal Philips
    • Boston Scientific Corporation
    • Johnson & Johnson

Recent Developments

  • June 2020: Boston Scientific Corporation introduced DIRECTSENSE Technology, a device for tracking how radiofrequency (RF) energy is delivered during cardiac ablation procedures. Furthermore, the DIRECTSENSE Technology offers information on the impedance around the catheter tip to gauge the tissue's responsiveness to RF radiation.
  • August 2022: Medtronic plc acquired Affera, Inc. to extend the first-ever cardiac mapping and navigation platform, which includes radiofrequency ablation solution, to the company's cardiac ablation product line. Further, this acquisition gives the company access to the Affera Prism-1 cardiac mapping and navigation platform, which is compatible with both Medtronic therapeutic catheters and a variety of competing technologies.
  • Report ID: 4032
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of gastrointestinal radiofrequency ablation systems is evaluated at USD 4.83 billion.

The global gastrointestinal radiofrequency ablation systems market size was worth over USD 4.54 billion in 2025 and is poised to grow at a CAGR of around 7.1%, reaching USD 9.01 billion revenue by 2035.

North America is anticipated to capture a 35% share of the Gastrointestinal Radiofrequency Ablation Systems Market by 2035, stemming from the increasing incidence of stomach cancer.

Key players in the market include ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc.

Gastrointestinal Radiofrequency Ablation Systems Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos